Moderna says its COVID-19 vaccine is safe and effective in kids between 6 and 11

Moderna
(Image credit: JUSTIN TALLIS/AFP via Getty Images)

Moderna's COVID-19 vaccine generated a "strong immune response" among children between the ages of 6 and 11, the company has announced.

Moderna revealed the interim results from a trial consisting of 4,753 participants between the ages of 6 and 11, and it said the vaccine was well-tolerated and generated a strong immune response, CNN reports. "The majority of adverse events were mild or moderate in severity," the company said. In the trial, two doses were given to children 28 days apart. The children received smaller doses than adults.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Brendan Morrow

Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.